Evaluation of the effect of Beraksurf and Cursorf in patients with respiratory distress

Phase 3

Recruiting

• Conditions: P22.0; respiratory distress syndrome.; Respiratory distress syndrome of newborn

• Registration Number: IRCT20120126008827N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Gestational age < 37 weeks
Radiologic and clinical diagnosis during first 6 hours,
Need to Fio2>30% for keeping o2 saturation 92-95% that measured by pulse oximetry

Exclusion Criteria

Patients with congenital disease and anomalies
Receiving two types of surfactant due to lack or shortage of the drug
Patients need operation
Neonates with congenital heart or lung disease or abdominal pathology

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment of respiratory distress syndrome. Timepoint: evaluate respiratory condition of neonates at birth and 2, 6,12,18,24,36,48 and 72 hour after birth. Method of measurement: Beraksurf case report form.